Search Results - "Mochida, Hideki"
-
1
Avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction
Published in The Journal of urology (01-08-2012)“…We investigated the in vitro inhibitory effects of avanafil, a novel, potent inhibitor of phosphodiesterase-5, on 11 phosphodiesterases. We also studied its…”
Get more information
Journal Article -
2
Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches
Published in Journal of molecular and cellular cardiology (01-12-2009)“…Abstract Myocardial infarction (MI) leading to myocardial cell loss represents one of the common causes leading to cardiac failure. We have previously…”
Get full text
Journal Article -
3
Effects of aging and uninephrectomy on renal changes in Tsukuba hypertensive mice
Published in Biomedical reports (01-05-2013)“…Renal dysfunction is accelerated by various factors such as hypertension, aging and diabetes. Glomerular hyper-filtration, considered one of the major risk…”
Get full text
Journal Article -
4
Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
Published in Journal of medicinal chemistry (28-03-2024)“…Relaxin H2 is a clinically relevant peptide agonist for relaxin family peptide receptor 1 (RXFP1), but a combination of this hormone’s short plasma half-life…”
Get full text
Journal Article -
5
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
Published in Journal of medicinal chemistry (28-03-2024)“…Optimization of the highly potent and selective, yet metabolically unstable and poorly soluble hRXFP1 agonist AZ7976 led to the identification of the clinical…”
Get full text
Journal Article -
6
mRNAs in urinary nano‑extracellular vesicles as potential biomarkers for non‑invasive kidney biopsy
Published in Biomedical reports (01-01-2021)“…Urinary nano-extracellular vesicles (NVs), including exosomes and microvesicles, are considered potential biomarkers for kidney diseases using liquid biopsies…”
Get full text
Journal Article -
7
Avanafil, a highly selective phosphodiesterase type 5 inhibitor for erectile dysfunction, shows good safety profiles for retinal function and hemodynamics in anesthetized dogs
Published in The Journal of urology (01-08-2013)“…We evaluated the effects of the highly selective phosphodiesterase type 5 inhibitor avanafil on electroretinogram and hemodynamics in dogs, and compared the…”
Get more information
Journal Article -
8
8-(3-Chloro-4-methoxybenzyl)-8H-pyrido[2,3-d]pyrimidin-7-one derivatives as potent and selective phosphodiesterase 5 inhibitors
Published in Bioorganic & medicinal chemistry letters (01-04-2015)“…[Display omitted] A novel series of highly selective phosphodiesterase 5 (PDE5) inhibitors was found. 8H-Pyrido[2,3-d]pyrimidin-7-one derivatives bearing an…”
Get full text
Journal Article -
9
Role of adenosine and P2 receptors in the penile tumescence in anesthetized dogs
Published in European journal of pharmacology (03-08-2001)“…We studied the role of adenosine and P2 receptors in the pelvic nerve stimulation-induced penile tumescence in anesthetized dogs. A local intracavernous…”
Get full text
Journal Article -
10
Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta
Published in European journal of pharmacology (05-04-2002)“…The vasorelaxant effects of sildenafil and T-1032 [methyl-2-(4-aminophenyl)-1,2-dihydro-1-oxo-7-(2-pyridinylmethoxy)-4-(3,4,5-trimethoxyphenyl)-3-isoquinoline…”
Get full text
Journal Article -
11
T-0156, a novel phosphodiesterase type 5 inhibitor, and sildenafil have different pharmacological effects on penile tumescence and electroretinogram in dogs
Published in European journal of pharmacology (06-02-2004)“…T-0156 (2-(2-methylpyridin-4-yl)methyl-4-(3,4,5-trimethoxyphenyl)-8-(pyrimidin-2-yl)methoxy-1,2-dihydro-1-oxo-2,7-naphthyridine-3-carboxylic acid methyl ester…”
Get full text
Journal Article -
12
Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum
Published in European journal of pharmacology (05-01-2001)“…This study was designed to examine the pharmacological properties of T-1032…”
Get full text
Journal Article -
13
Enzymological and pharmacological profile of T-0156, a potent and selective phosphodiesterase type 5 inhibitor
Published in European journal of pharmacology (05-12-2002)“…The enzymological and pharmacological properties of…”
Get full text
Journal Article -
14
Effects of high cell density on growth-associated monoclonal antibody production by hybridoma T0405 cells immobilized in macroporous cellulose carriers
Published in Biotechnology and bioprocess engineering (01-04-2000)“…Relationship between monoclonal antibody (MAb) productivity and growth rate, and effects of high cell density on MAb production of hybridoma T0405 cells…”
Get full text
Journal Article -
15
Effects of adenosine- and P2-receptor antagonists on the penile tumescence in the anesthetized dogs
Published in Japanese Journal of Pharmacology (2001)“…We studied the effects of adenosine- and purinergic P2-receptor antagonists on the penile tumescence in the anesthetized dogs. Intracavernous adenosine (1 mM,…”
Get full text
Journal Article